Drug Shortage Report for 20% PROSOL
Report ID | 24792 |
Drug Identification Number | 02141450 |
Brand name | 20% PROSOL |
Common or Proper name | 20% PROSOL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PHENYLALANINE HISTIDINE TRYPTOPHAN LEUCINE ARGININE THREONINE ALANINE DL-METHIONINE GLYCINE GLUTAMIC ACID PROLINE L-ASPARTIC ACID TYROSINE LYSINE SERINE VALINE ISOLEUCINE |
Strength(s) | 1G 1.18G 0.32G 1.08G 1.96G 0.98G 2.76G 0.76G 2.06G 1.02G 1.34G 0.6G 0.05G 1.35G 1.02G 1.44G 1.08G |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 2000 mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-11-15 |
Actual start date | 2017-11-15 |
Estimated end date | 2017-12-15 |
Actual end date | 2017-11-21 |
Shortage status | Resolved |
Updated date | 2017-11-22 |
Company comments | Customers can use the following alternate code upon their clinical judgement: JB6584- Travasol 10% 1000 ml |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-11-22 | English | Compare |
v7 | 2017-11-21 | French | Compare |
v6 | 2017-11-21 | English | Compare |
v5 | 2017-11-16 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-10-10 | English | Compare |
v2 | 2017-10-10 | French | Compare |
v1 | 2017-10-10 | English | Compare |
Showing 1 to 8 of 8